The transcatheter heart valve replacement (TAVR) market is reported to reach a valuation of at USD 8.18 billion in 2025 to USD 32.82 billion by 2035. Demand for TAVR is expected to rise at a CAGR of ...

The recent EARLY TAVR trial (Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis) investigated the effect of early intervention with transcatheter aortic ...

Mechanical Aortic Valves: The researchers reviewed data on nearly 110,000 patients who underwent surgical replacement of aortic valves between the ages of 40 and 79. They found that in those aged ...

“The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement,” study leader Dr. Michael Bowdish of Cedars-Sinai ...

Source Reference: Bowdish ME, et al "Bioprosthetic vs mechanical aortic valve replacement in patients 40-75 years" J Am Coll Cardiol 2025; DOI: 10.1016/j.jacc.2025.01.013.

“The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement,” said Dr. Michael Bowdish, lead author of the study ...

Pro-T-TEER: Safety Comes First, Risk of Replacement Outweighs the Benefits! Presenter: Sam Dawkins. June 05, 2024. More slides + Presentation NY Valves 2024. Case Resolution: A Non-Surgical Patient ...

Long‐term outcomes of patients undergoing aortic root replacement with mechanical versus bioprosthetic valves: meta‐analysis of reconstructed time‐to‐event data. https://www.ahajournals ...

Aortic valve repair offers an alternative to aortic replacement. While it restores function and alleviates symptoms, replacement may be needed in some cases due to severe damage or repair complexity.

After bioprosthetic aortic valve replacement, patients who took the oral drug warfarin had better outcomes including lower mortality rates and fewer blood clots, according to new research from ...

Benefit of Anticoagulation Early After Surgical Aortic Valve Replacement Using Bioprosthetic Valves. Mayo Clinic Proceedings , 2023; 98 (12): 1797 DOI: 10.1016/j.mayocp.2023.08.012 Cite This Page : ...

Mayo Clinic researchers analyzed nationwide data on more than 10,000 patients who underwent bioprosthetic aortic valve replacement. Warfarin use was associated with a 32% reduction in mortality risk.